Population Health Management Market 2022 Key Players McKesson, IBM, Cerner Corporation, Conifer Health Solutions, Health Catalyst

The healthcare expenditure is increasing across the globe with increasing prevalence of diseases, high healthcare cost, and increasing government and non-government initiatives. According to the World Health Organization (WHO), the increase in total healthcare expenditure is leading to the improvement in healthcare infrastructure. The increase in healthcare expenditure further develops the HIT infrastructure, as high healthcare cost increases the demand for health analytics.

Download report sample at: http://bit.ly/2za58Lf

The governments in different countries are investing significant portion of their GDP for healthcare. Although, there are huge variations among the healthcare spending of different countries, healthcare has been one of the primary focus for all. Healthcare spending in the developed economies of North America and Europe is considerably higher in comparison to the developing countries. The lower spending in developing countries is primarily due to their low-income per capita GDP. However, per capita healthcare spending in developing countries is increasing due to the increasing government initiatives. The increasing healthcare expenditure leads to the increased demand for PHMs, thus driving the growth of the global PHM market.

Some of the key companies operating in the global population health management market include Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., Wellcentive Inc., Conifer Health Solutions LLC., IBM Corporation, Optum, Inc., and Health Catalyst LLC.

Browse report at: http://bit.ly/2olTAfK

Geographically, the Asia PHM market is in its nascent stage. However, a high growth is predicted during the forecast period in Asia due to the improving healthcare infrastructure, increasing need for better health outcomes, and increasing prevalence of chronic and lifestyle associated diseases.

According to the WHO’s Global Tuberculosis Report, out of 9.6 million of new tuberculosis cases in 2014 in Asia-Pacific, 58% of the cases were in the South East Asia and Western Pacific region. The organization also reported that about 3,065,000 cancer cases (excluding non-melanoma skin cancer) from China and about 1,015,000 cancer cases (excluding non-melanoma skin cancer) from India in 2012. The PHM is beneficial in improving health outcomes of different population group at low cost. PHM vendors and government agencies would have to invest huge capital at initial stages in order to fully exploit the market potential in the region.

Pre-Purchase Inquiry at: http://bit.ly/2Tvs7bi

Few years ago. the largest revenue in the global PHM market was generated from the web based PHM, which accounted for 68.9% of the total global revenue. Although, conventional methods of data gathering and analyzing could be a substitute of PHM, these are least prefer methods as these include high cost and complexities in operations. Therefore, the threat of substitutes is low in the global PHM market, as no specific substitutes of PHM are available in the market. The buyer propensity towards the substitute is also low due to lack of availability of better substitute.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.